Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare DAPAGLIFLOZIN (FARXIGA) and Sitagliptin (Januvia) — clinical data, side effects, and patient experiences.
FARXIGA, Farxiga · Other
How it works
12.1 Mechanism of Action Sodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose fr...
Approved for
Januvia, ZITUVIMET · DPP-4 Inhibitor
How it works
Inhibits dipeptidyl peptidase-4 (DPP-4) enzyme, slowing the inactivation of incretin hormones GLP-1 and GIP, thereby increasing insulin release and decreasing glucagon levels in a ...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 30 Reddit discussions
DAPAGLIFLOZIN
20%
positive
15 threads
Sitagliptin
40%
positive
15 threads
% of discussions mentioning each side effect
Based on 1 verified patient review
No data yet
No data yet
Avg. Duration
0 months
0% still taking
Avg. Duration
18 months
100% still taking
DAPAGLIFLOZIN is a Other, while Sitagliptin belongs to the DPP-4 Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.
Sitagliptin has an average efficacy rating of 7.0/10 and tolerability of 9.0/10 across 1 patient review. Patient-reported outcomes provide real-world context beyond clinical trials, though individual responses to medication vary significantly..
DAPAGLIFLOZIN carries 4 FDA warnings. Sitagliptin carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.